Chengdu Suncadia Medicine Co., Ltd.
Clinical trials sponsored by Chengdu Suncadia Medicine Co., Ltd., explained in plain language.
-
New drug HRS-3095 aims to soothe stubborn hives
Symptom relief Not yet recruitingThis Phase 2 trial tests whether the experimental drug HRS-3095 can reduce itching and wheals in adults with chronic spontaneous urticaria (hives) that isn't well controlled by antihistamines. About 190 participants will receive either the drug or a placebo daily for 4 weeks. The…
Phase: PHASE2 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New oral drug for eczema takes first step in human safety trial
Knowledge-focused Not yet recruitingThis early-stage study tests the safety and tolerability of an experimental oral drug called HRS-8797 in healthy volunteers aged 18 to 55. Researchers will also measure how the drug behaves in the body and whether food affects its absorption. The goal is to gather essential safet…
Phase: PHASE1 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC